UBS’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $394K | Sell |
25,159
-3,815
| -13% | -$59.7K | ﹤0.01% | 3324 |
|
|
2014
Q2 | $430K | Sell |
28,974
-4,208
| -13% | -$62.5K | ﹤0.01% | 3277 |
|
|
2014
Q1 | $534K | Buy |
33,182
+29,982
| +937% | +$483K | ﹤0.01% | 3115 |
|
|
2013
Q4 | $30K | Sell |
3,200
-15,869
| -83% | -$149K | ﹤0.01% | 4927 |
|
|
2013
Q3 | $216K | Buy |
19,069
+18,069
| +1,807% | +$205K | ﹤0.01% | 3469 |
|
|
2013
Q2 | $13K | Buy |
+1,000
| New | +$13K | ﹤0.01% | 5148 |
|